Skip to content

Updates

Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.

Type
Blogs Testimonial
Sectors
Agriculture Biotech Chemicals Cosmetics Diagnostics Digital Health Food and Feed Healthcare Medical Devices Pharmaceuticals
Expertises (2)
Advertising and Claims Commercial Contracts Corporate, Governance and Boardroom Counselling Data Protection, (Cyber)security and AI Due Diligence Environmental and Sustainability Financing and M&A Intellectual Property and Licensing Litigation Regulatory Compliance and Enforcement Spin-out and Starter Advisory Subsidies and Grants
Intellectual Property and Licensing Remove filter Regulatory Compliance and Enforcement Remove filter Clear all

65 results

Newest first
Newest first Oldest first A–Z Z–A
Medical Devices Regulatory Compliance and Enforcement Testimonial

We have advised numerous manufacturers on MDR and IVDR compliance, including guiding a small medical device company through the conformity assessment procedure with its notified body.

Healthcare Pharmaceuticals Regulatory Compliance and Enforcement Testimonial

We have advised pharmacies on the regulatory aspects of pharmaceutical compounding.

Biotech Pharmaceuticals Commercial Contracts Intellectual Property and Licensing Testimonial

Axon advised a stock-listed biopharmaceutical company on antibody licensing and technology transfer agreements with two major US-based pharmaceutical companies. The deals involved the grant of commercial rights to the licensor's proprietary antibody platform technology.

Agriculture Biotech Intellectual Property and Licensing Testimonial

Axon advised a Dutch joint venture, that is active within the agri-food and agricultural biotechnology sector, on the transfer of its assets to a German investment fund. The transferred assets involved patent rights, plant breeders’ rights, trade secrets and biological materials.

Biotech Corporate, Governance and Boardroom Counselling Intellectual Property and Licensing Spin-out and Starter Advisory Testimonial

Axon regularly advises spin-outs from academic institutions on a wide range of topics. We make sure that the spin-out’s license agreement includes commercially and legally viable terms and is attractive to investors. In addition, we advise on the corporate structure of the spin-out, balancing the interest of the founders, the academic institution and all other stakeholders.